Skip to main content
BMJ Neurology Open logoLink to BMJ Neurology Open
. 2024 May 27;6(1):e000754. doi: 10.1136/bmjno-2024-000754

Spontaneous spinal cord infarction: a systematic review

Maria Gharios 1,0, Vasilios Stenimahitis 1,2,0, Victor Gabriel El-Hajj 1, Omar Ali Mahdi 1, Alexander Fletcher-Sandersjöö 1, Pascal Jabbour 3, Magnus Andersson 1, Claes Hultling 4, Adrian Elmi-Terander 1,5,6,7,, Erik Edström 1,5,6
PMCID: PMC11138300  PMID: 38818241

Abstract

Background and objectives

Spontaneous spinal cord infarction (SCInf) is a rare condition resulting in acute neurological impairment. Consensus on diagnostic criteria is lacking, which may present a challenge for the physician. This review aims to analyse the current literature on spontaneous SCInf, focusing on epidemiology, the diagnostic process, treatment strategies and neurological outcomes.

Methods

The study was performed in accordance with a previously published protocol. PubMed, Web of Science and Embase were searched using the keywords ‘spontaneous’, ‘spinal cord’, ‘infarction’ and ‘ischaemic’. The eligibility of studies was evaluated in two steps by multiple reviewers. Data from eligible studies were extracted and systematically analysed.

Results

440 patients from 33 studies were included in this systematic review. Analysis of vascular risk factors showed that hypertension was present in 40%, followed by smoking in 30%, dyslipidaemia in 29% and diabetes in 16%. The severity of symptoms at admission according to the American Spinal Injury Association (ASIA) Impairment Scale was score A 19%, score B14%, score C36% and score D32%. The mean follow-up period was 34.8 (±12.2) months. ASIA score at follow-up showed score A 11%, score B 3%, score C 16%, score D 67% and score E 2%. The overall mortality during the follow-up period was 5%. When used, MRI with diffusion-weighted imaging (DWI) supported the diagnosis in 81% of cases. At follow-up, 71% of the patients were able to walk with or without walking aids.

Conclusion

The findings suggest a significant role for vascular risk factors in the pathophysiology of spontaneous SCInf. In the diagnostic workup, the use of DWI along with an MRI may help in confirming the diagnosis. The findings at follow-up suggest that neurological recovery is to be expected, with the majority of patients regaining ambulation. This systematic review highlights gaps in the literature and underscores the necessity for further research to establish diagnostic criteria and treatment guidelines.

Keywords: STROKE


WHAT IS ALREADY KNOWN ON THIS TOPIC

  • Spinal cord infarction (SCInf) is a rare condition leading to significant neurological impairment. However, definitive diagnostic criteria and treatment guidelines are still lacking.

WHAT THIS STUDY ADDS

  • This systematic review provides a comprehensive summary of spontaneous SCInf, focusing on its epidemiology, clinical presentation, risk factors, diagnosis, treatment and outcomes.

HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY

  • This study summarises the available literature regarding the diagnosis, treatment and prognostic factors of spontaneous SCI. It also offers a flowchart with suggested diagnostic and treatment strategies, as well as expert recommendations. Furthermore, it underscores the need for further research in order to establish definitive diagnostic criteria and treatment strategies.

Introduction

Spinal cord infarction (SCInf) constitutes approximately 6% of all acute myelopathic syndromes1 and 1.2% of all strokes.2,5 It arises either within a periprocedural context, attributed to aortic disease and repair surgery,6 7 or as a spontaneous pathology.8,10 Like cerebral strokes, the occurrence of spontaneous SCInf has been ascribed to the interplay between various vascular risk factors such as diabetes, hypertension and hyperlipidaemia.11 12 Yet, the exact aetiology behind spontaneous SCInf has not been clarified.11

The clinical presentation of SCInf ranges from transient sensory disturbances to severe paraplegia or tetraplegia.1 13 Nonetheless, acute severe back pain in approximately 70% of the cases,14 followed by a prompt debut of neurological deficits, are described as distinguishing features.15 Additionally, impairment of autonomic functions along with bladder and bowel dysfunction may occur.6 16 17

The differential diagnosis presents a serious challenge since the acute symptomatology in SCInf is analogous to many other neurological conditions, such as inflammatory myelopathies, multiple sclerosis, malignancy and infectious myelopathies.6 16 MRI plays an important role in the diagnostic process. Recently, Zalewski et al18 have proposed criteria for the diagnosis of both spontaneous and periprocedural SCInf based on clinical, radiological and cerebrospinal fluid (CSF) findings.

Established treatment protocols are lacking. Management strategies reflect those used in cerebral stroke19 with antiplatelet therapy, management of cardiovascular risk factors and intensive neurological rehabilitation.

While a rare diagnosis, SCInf has devastating consequences for the individual, and the limited knowledge on the aetiology, diagnostics and treatment options prompts further research. In that context, this systematic review aimed to highlight the current knowledge on spontaneous SCInf and provide an overview of the existing data.

Materials and methods

This systematic review is in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses20 guidelines (online supplemental file 1). The review protocol was registered within the International Prospective Register of Systematic Reviews (registration ID: CED42023393241; registration date: 24/02/2023). The study protocol was published.21

Databases and search strategy

Electronic search engines, including PubMed, Web of Science and Embase, were searched using different combinations of the following keywords: ‘spontaneous’, ‘spinal cord’, ‘infarction’ and ‘ischaemic’. The detailed search strategy for each of the search engines is included in online supplemental file 2.

Inclusion criteria

Types of studies

All peer-reviewed and original studies, written in English and available in the PubMed, Embase or Web of Science databases from inception and onwards, will be eligible for inclusion.

Types of participants

All patients with spontaneous spinal cord infarctions will be included, regardless of age, ethnicity and sex.

Types of outcome measurements

Epidemiological data such as age, sex and socioeconomic factors, risk factors, diagnosis and management strategies, outcomes and predictors will all be addressed. Furthermore, outcome parameters, including pathological mechanisms, quality of life and mortality, will be explored with sufficient data.

Exclusion criteria

Non-original publications such as reviews, editorials and letters to the editor will be disregarded, along with conference abstracts and case reports. Non-spontaneous cases of SCInf occurring after clear inciting events, such as surgery, trauma or hypovolemic shock, will be disregarded and excluded from the analysis. Studies containing both spontaneous and non-spontaneous SCInf cases will only be retained if data on spontaneous cases can be separately extracted. Studies only addressing SCInfs secondary to vertebral artery dissections will also be excluded, as this topic has specifically been addressed in a previous systematic review.22

Study selection

Searches across all search engines from inception until 2023 yielded a total of 743 publications. After duplicate removal, the remaining studies were transferred to Rayyan, where the selection process took place.23 The studies were first screened based on titles and abstracts by two independent and blinded reviewers (VS and MG). Then, full-text articles were assessed by the same independent and blinded reviewers. Inter-reviewer conflicts were resolved through discussion and a third reviewer (AET) was consulted as needed.

Data extraction and synthesis

Data from selected records was extracted using a predefined extraction template, preliminary including (1) general information—title, first author, journal, publication year, etc; (2) study characteristics—study type, sample size, follow-up time, etc; (3) patient characteristics and epidemiology—age, sex, spinal segment involved, presenting symptoms and neurological function, etc; (4) diagnosis and treatment characteristics—diagnostic modalities, treatment strategy, etc; and (5) outcomes—neurological outcomes, predictors of outcome, quality of life, etc. The collaboration of multiple reviewers will be sought to achieve a thorough extraction of the data. The final work will be assessed and cross-checked to prevent any errors.

Risk of bias and evidence certainty assessment

The risk of bias was assessed using the Newcastle-Ottawa scale (NOS), a scoring system designed for observational studies that allows a maximum of nine points per study. The results of this assessment are provided (online supplemental file 3).

Results

The search strategy yielded 743 studies across three different search engines. Screening of these studies as well as an additional 28 identified from reference list searching resulted in the final inclusion of 33 studies involving 440 patients with spontaneous SCInf (figure 1). For studies with overlapping cohorts, the data were only considered once to avoid duplicate data. Baseline characteristics are presented in table 1.

Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 flow diagram.

Figure 1

Table 1. Baseline characteristics.

Study title Study ID n Spontaneous SCInf (%) Mean age % Males
MR imaging of spontaneous spinal cord infarction. Elksnis (1991)13 3 3 50 0%
Spontaneous thoracolumbar spinal cord infarction: report of six cases. Monteiro (1992)30 6 6 57 50%
MR imaging of spinal cord and vertebral body infarction. Yuh (1992)66 12 3 53 100%
Spinal infarction. A follow-up study. Pelser (1993)67 10 8 58 62.50%
Spinal cord infarction: etiology and outcome. Cheshire (1996)34 44 4 63 Not specified
Vertebral body infarction as a confirmatory sign of spinal cord ischemic stroke: report of three cases and review of the literature Faig (1998)1 3 3 53 33.30%
Non-traumatic ischaemic myelopathy: a review of 25 cases. Kim (1988)40 25 7 68 100%
Spinal cord infarction: MR imaging and clinical features in 16 cases. Weidauer (2002)39 16 8 66 62.50%
Diffusion-weighted MR imaging (DWI) in spinal cord ischemia. Thurnher (2006)50 6 3 Not specified 33.30%
Vertebral body signal changes in spinal cord infarction: histopathological confirmation. Srikanth (2007)26 5 5 50 80%
Spinal cord infarction in Chinese patients. Clinical features, risk factors, imaging and prognosis. Cheng (2008)31 22 15 58 40%
Clinical evaluation of patients with spinal cord infarction in Mashhad, Iran. Ghandehari (2010)25 14 7 41 14.30%
Clinical core symptoms of posterior spinal artery ischemia. Struhal (2011)6 4 3 68 66.70%
Acute spinal-cord ischemia: evolution of MRI findings. Alblas (2012)33 5 3 60 33.30%
Retrospective case series of outcomes following spinal cord infarction. New (2012)10 44 11 Not specified 36.40%
Recovery after spinal cord infarcts: long-term outcome in 115 patients. Robertson 201236 115 24 64 Not specified
Survival following spinal cord infarction. New (2013)8 44 11 Not specified 36.40%
Three unique presentations of atraumatic spinal cord infarction in the pediatric emergency department. Spencer (2014)9 3 3 11 33.30%
Nontraumatic spinal cord ischaemic syndrome. Rigney 20157 8 4 58 25%
Diagnostic and prognostic relevance of magnetic resonance imaging and electrophysiological findings in acute spinal ischemia Artemis (2017)16 10 10 63 50%
Childhood idiopathic spinal cord infarction: description of 7 cases and review of the literature. Bar (2017)17 7 7 14 14.30%
Delayed hospital presentation and neuroimaging in non-surgical spinal cord infarction. Pikija (2017)48 39 27 68 51.90%
A population-based study of the incidence of acute spinal cord infarction. Qureshi (2017)35 8 5 64 40%
Spinal cord infarction: clinical and radiological features. Yadav 201824 17 12 28 58.30%
Spontaneous posterior spinal artery infarction: an under-recognized cause of acute myelopathy. Zalewski (2018)68 15 15 Not specified 40%
Characteristics of spontaneous spinal cord infarction and proposed diagnostic criteria. Zalewski (2019)18 133 133 60 46.62%
Acute spontaneous spinal cord infarction: utilisation of hyperbaric oxygen treatment, cerebrospinal fluid drainage and pentoxifylline. Ashton (2020)28 13 13 55 53.80%
Spinal cord transient ischemic attack: Insights from a series of spontaneous spinal cord infarction. English (2020)15 133 133 60 46.60%
Etiology and outcomes of spinal cord infarct: a case series from a level 1 trauma center. Ge (2020)5 30 6 Not specified Not specified
Spinal cord infarction: a single center experience and the usefulness of evoked potential as an early diagnostic tool. Park (2020)37 14 13 65 61.50%
Serum neurofilament to magnetic resonance imaging lesion area ratio differentiates spinal cord infarction from acute myelitis. Sechi (2021)29 48 20 56 50%
Spontaneous spinal cord infarction in Austria: a two-center comparative study. Pikija (2022)14 88 71 64 45.10%
Long-term outcomes following periprocedural and spontaneous spinal cord infarctions: a population-based cohort study Stenimahitis (2023)38 57 30 65 53.30%

Sex was specified for 406 patients, of whom 48% were male. A pooled mean age of 58.7±3.96 was calculated from 26 studies on 420 patients,16 7 9 13 16 17 24,39 while two studies14 18 only provided the median ages of 60 and 64 years, respectively. Information on vascular risk factors was present in 17 studies on a total of 264 patients.16 7 9 13 16 18 24 28 30 32 33 35 37,40 Hypertension, identified in 40% of patients, was notably the most common risk factor, followed by smoking (30%), dyslipidaemia (29%) and diabetes (16%), while 28% had no reported vascular risk factors (table 2).

Table 2. Patient demographics and vascular risk factors.

Total number of patients included 440
Demographics
Male sex 195 (48%)
Age n=420
Mean±SD 58.7±3.96
Vascular risk factors n=264
 Hypertension 106 (40%)
 Dyslipidaemia 77 (29%)
 Diabetes 41 (16%)
 Smoking 79 (30%)
 Atrial fibrillation 14 (5.3%)
 History of stroke or transient ischaemic attack 9 (3.4%)
 History of ischaemic heart disease 25 (9.5%)
 Peripheral vascular disease 12 (4.5%)
Obesity 3 (1.1%)
No vascular risk factors 75 (28%)

Nineteen studies presented information on the clinical presentation of patients with spontaneous SCinf (table 3).16,9 13 14 16 The presenting symptoms reported most frequently were motor deficits (92%), sensory deficits (85%), autonomic dysfunction (76%) and pain (70%). Neurological function on admission was reported in eight studies on 106 patients.5 7 8 14 16 28 35 38 However, for 11 patients, the individual American Spinal Injury Association (ASIA) Impairment Scale score was not provided, as the authors only mentioned that nine patients had an ASIA score of A, B or C and two had an ASIA score of D.8 Consequently, individual ASIA scores were reported for 95 patients. Among them, 18 patients (19%) had an ASIA score of A, 13 (14%) had an ASIA score of B, 34 (36%) had an ASIA score of C and 32 (32%) had an ASIA score of D. None of the patients were neurologically intact on admission. Furthermore, information on the time to nadir in terms of neurological function was found in four studies on 182 patients.17 18 24 38 Of these, 148 (81%) reached nadir within 12 hours, 20 (11%) between 12 and 24 hours and 14 (7.7%) after 24 hours.

Table 3. Symptoms and neurological function on admission.

Symptoms N (%)
Motor deficits (n=336) 310 (92%)
Sensory deficits (n=307) 260 (85%)
Pain (n=318) 223 (70%)
Bladder and bowel dysfunction (n=315) 239 (76%)
American Spinal Injury Association Impairment Scale Score (n=95)
 A 18 (19%)
 B 13 (14%)
 C 34 (36%)
 D 30 (32%)
Neurologically intact 0 (0%)
Time to nadir (n=182)
<12 hours 148 (81%)
12–24 hours 20 (11%)
>24 hours 14 (7.7%)

MRI was used in the assessment of 371 patients. Two hundred and seventy-nine patients showed pathological MRI findings at the initial MRI. Information regarding the time to the initial MRI was provided for 162 patients. Most of these patients (90%) were examined after 1 day, mainly between 1 and 2 days. A minority (10%) was examined within 1 day of presentation. In 92 patients, the initial MRI was normal. For 52 of these patients, imaging was performed within the first 24 hours after symptoms onset, for two after 1 day, and for the remainder, this information was not provided. In 90 patients with an initially normal MRI, a repeat MRI performed 1.5–42 days after admission showed abnormalities consistent with SCInf in 83 patients. Only 87 patients had diffusion-weighted imaging (DWI) performed, revealing diffusion restriction in 71 of them (82%). Regarding the affected spinal levels, the most involved levels were thoracic (33%), followed by cervical (24%), thoracic through lumbar (26%), cervical through thoracic (13%), isolated conus (5%) and cervical through conus (0.5%) (table 4).

Table 4. MRI findings.

Patients with positive initial MRI n=279
 Time to MRI
 Between 0 and 1 day 26
 More than 1 day 146
 Not stated 107
Patients with negative initial MRI n=92
 Time to initial MRI
 Between 0 and 1 day 52
 More than 1 day 2
 Not stated 38
 Time to second MRI n=90
 Between 1 and 4 days 22
 More than 4 days 30
 Not stated 38
Inconclusive MRI findings 7
MRI findings suggestive of SCinf 83
Lesion levels n=345
Cervical 81 (24%)
Thoracic 113 (33%)
Cervical through thoracic 43 (13%)
Thoracic through lumbar 88 (26%)
Isolated conus 18 (5.2%)
Cervical through conus 2 (0.5%)

ScInf, spinal cord infarction.

Results of the CSF analysis were reported in 13 studies on 174 patients.17 9 13 16,18 30 33 34 36 The analysis was normal in 70 (40%) of these patients, while high protein levels were the most common pathological finding seen in 85 (49%) patients. Oligoclonal bands were reported in two patients (1%) (table 5).

Table 5. Results of the CSF analysis in patients with spontaneous SCInf.

CSF analysis Number of patients=174
Normal 70 (40%)
High protein 85 (49%)
Pleocytosis 21 (12%)
Supernumerary oligoclonal bands 2 (1.1%)

CSF, cerebrospinal fluid; ScInf, spinal cord infarction.

Data on the status of patients at follow-up were obtained from 20 studies (table 6).16,9 13 16 The pooled mean follow-up time, calculated from 16 studies on 143 patients, was 35 months.16 7 9 13 17 28 30,32 34 The median follow-up time was presented in two studies and ranged from 1 to 1.9 months.16 18 In one study on six patients, the follow-up period ranged from 15 to 41 weeks.24 One study did not mention follow-up duration.33 Among the patients with information regarding ambulation (n=204), the majority, 42%, were independently ambulatory, 29% were ambulatory with aids, 29% were wheelchair dependent and only a single patient (0.5%) was bedridden. ASIA scores were recorded for 190 patients. Twenty-one (11%) patients had an ASIA score of A, six (3%) B, 31 (16%) C, 129 (67%) D and 4 (2%) E. In seven studies on 29 patients, 23 were reported to have motor deficits at follow-up without specifying the ASIA. Twelve patients had sensory deficits (n=17), and 33 patients had autonomic dysfunction (n=55). The mortality rate among patients with follow-up was calculated to be 5% (16/297).

Table 6. Follow-up.

Total number of patients with available follow-up 297
Mean follow-up period (months)±SD 34.8±12.2
American Spinal Injury Association Impairment Scale at follow-up n=190
 A 21 (11%)
 B 6 (3.2%)
 C 31 (16%)
 D 128 (67%)
 E 4 (2.1%)
Motor deficits (n=215) 209 (97%)
Motor deficits, no American Spinal Injury Association Impairment Scalereported (n=29) 23 (79%)
Sensory deficits (n=17) 12 (71%)
Autonomic dysfunction (n=55) 33 (60%)
Ambulation at follow-up (n=204)
Wheel-chair dependent 59 (29%)
Ambulatory with aids 59 (29%)
Independently ambulatory 85 (42%)
Bed ridden 1 (0.5%)

Before the diagnosis of SCInf was established, the most common treatment was corticosteroids (n=77). Other, less frequently used treatments were intravenous immunoglobulin (n=18), plasma exchange (n=12), thrombolysis (n=2), azathioprine (n=1), mycophenolate (n=1) and rituximab (n=1). After establishing a diagnosis of spinal cord infarction, 193 patients received antiplatelet therapy, 12 anticoagulation and two thrombolysis.

In two studies, young age at onset was a predictor of adverse outcomes.14 31 In the first study, younger age at onset (<55 years) was statistically correlated with poor motor recovery.31 In the second study, bed-ridden patients on discharge were more likely to be younger (median 57 years, IQR=53–61), compared with other functional conditions (wheelchair, able to walk with help, self-ambulatory) (median 63 years, IQR=55–73).14 In two other studies, age could not be associated with mortality.8 38

Three studies compared the outcomes of patients with SCInf of different aetiologies and found no statistical difference in the 1-year and 5-year survivals.8 17 38 Patients with spontaneous SCInf had better outcomes with improved ASIA scores and were more likely to be ambulatory at follow-up compared with patients with periprocedural SCInf.38 In a paediatric cohort, motor recovery was better in idiopathic SCInf.17 The latter study also noted that, compared with other aetiologies, spontaneous SCInf was more commonly the result of an insult to the anterior territory of the spinal cord.17

In a study analysing MRI localisation and SCInf outcomes, cervical lesions with anterior cord syndrome were associated with a better outcome than those with multiple-level lesions.14 In another study, there was no association between lesion level and survival.8 Other outcome predictors were hyperlipidemia and severe initial weakness, judged by low scores (≤2) on the Medical Research Council scale, both of which correlated with a poor outcome. Other vascular risk factors (such as diabetes, hypertension, heart/aortic disease and previous cerebral stroke) and bladder dysfunction did not reach statistical significance.31

Two studies compared clinical, imaging and electrophysiological findings between patients with SCInf and those with acute transverse myelitis.29 37 Compared with patients with transverse myelitis, patients with SCInf had significantly higher neurofilament light protein serum levels,29 more prolonged tibial somatosensory evoked potential latency and shorter lesion length on MRI.41 These studies suggested the use of new tools to aid in the diagnosis of SCInf. Sechi et al demonstrated that SCInf can be accurately distinguished from acute myelitis by the ratio between NFL and the largest sagittal lesion area on MRI.29 Park et al suggested the use of evoked potentials as a confirmatory test for an appropriate diagnosis of SCInf.37 Another study investigating the utility of electrophysiological studies in outcome prediction showed an association between ASIA score of E at follow-up and normal motor evoked potentials (MEPs). There was a trend for an association between unfavourable outcomes (ASIA score ≤C) and pathological MEP findings, but it did not reach significance.16

Discussion

While SCInf constitutes only a small part of myelopathic syndromes and an even smaller part of all stroke syndromes, its effects may be devastating. To improve outcomes, efforts towards improved diagnostic strategies are needed. In 2019, Zalewski et al proposed diagnostic guidelines for SCInf.18 Diagnostic categories are used to indicate the quality of the supporting findings. Thus, a definitive diagnosis of SCInf rests on typical clinical and MRI findings.

Currently, treatments focus on managing cardiovascular risk factors recognised in stroke. Although SCInfs share many similarities with cerebral strokes, they remain distinct entities.

Two aetiologies of SCInf have been recognised: periprocedural and spontaneous SCInfs. Periprocedural SCInf often occurs as a complication of vascular surgery, affecting the blood supply to the spinal cord. The remainder of SCInf is spontaneous, with pathophysiology resembling that of cerebral strokes. Since knowledge on the diagnosis, treatment and prevention of spontaneous SCInf is limited, this review aims to provide a comprehensive overview of the current knowledge on spontaneous SCInf.

Risk factors

In our pooled cohort of patients with spontaneous SCInf, at least one vascular risk factor was reported in 72% of patients, with the two most common being hypertension and smoking. Proper management of well-recognised cardiovascular risk factors, such as dyslipidaemia, diabetes, hypertension and smoking, is essential for the primary and secondary prevention of stroke, and arguably so, for SCInfs.42,44 However, the impact of cardiovascular risk factors on the pathophysiology of spontaneous SCInf is yet to be fully understood.45

Diagnostics

MRI remains the most important tool in establishing a diagnosis of SCInf. Distinct diagnostic findings on MRI include bilateral hyperintense lesions in the anterior horns (owl’s eyes) on transverse sections, pencil-like hyperintensities on sagittal sequences, and hyperintensities corresponding to the anterior spinal artery. In this pooled analysis, MRI was performed in 371 patients, with positive findings in 279. Most patients were examined within 48 hours and only a small part of them (10%) were examined within the first 24 hours. Reportedly, the sensitivity of early scans is extremely low.46 47 Up to half of T2-weighted imaging may not depict any spinal cord lesions within the first 24 hours after symptom onset.14 48 In our pooled analysis, we found that one-fourth of the initial scans could not support a definite diagnosis. In patients with an initially normal MRI, 92% had findings consistent with SCInf on a repeat MRI performed 1.5–42 days later. Overall, the relatively high positive predictive value of MRI in the total pooled cohort strengthens the importance of MRI in the diagnostic workup of SCInf. While the diagnostic value of early conventional MRI scans may be questioned in this context, it is important to consider the role of these scans in ruling out other differential diagnoses that may warrant other treatments in the acute phase, while keeping in mind that delayed scans may provide more conclusive results in the diagnosis of SCInf.

On another note, DWI is known to be superior as compared with conventional MRI in detecting early ischaemic lesions in stroke patients.49 Similarly, DWI may improve the diagnostic accuracy of MRI in SCInf.50 However, several anatomical and physiological aspects of spinal imaging complicate the use of DWI in this instance. These include the heterogeneity of the spinal column structures, the variability of blood supply and the pulsatile movement of the CSF and spinal cord.24 51 Nonetheless, there is limited data addressing the utility of DWI in the diagnostic workup of SCInf, with only 87 patients receiving DWI identified in this review. Regardless, the use of DWI in the workup of SCInf may assist in establishing a definite diagnosis and facilitate the elimination of other differentials.

Treatment

This review revealed that 41% of the patients were treated with corticosteroids based on the clinical suspicion of myelitis and prior to the establishment of a definite spontaneous SCInf diagnosis. The use of corticosteroids for the treatment of SCInfs, in an attempt to lower oxidative stress, lacks supporting evidence and has mainly been advocated by a few case reports.52,54 Corticosteroids may carry severe side effects, which ought to limit their use prior to the definitive establishment of a diagnosis. Similarly, the use of intravenous thrombolysis was also limited to a small number of patients, precluding definitive conclusions regarding the usefulness of this treatment option.55

Data regarding the treatment approach after the establishment of a definite SCInf diagnosis revealed that antiplatelet therapy was initiated in most of the cases (93%). Anticoagulation was prescribed in a limited number of cases (6%) and in two cases (1%) thrombolysis was administered. Nonetheless, the efficacy of these treatment modalities in preventing further deterioration is unknown due to the lack of controlled studies. Strategies such as mean arterial pressure elevation and lumbar CSF drainage,56 aiming to enhance spinal cord perfusion, have been used in the context of periprocedural SCInf. However, the role of these approaches in the management of spontaneous SCInf is poorly investigated.

Neurological recovery and ambulation

The recovery from a spinal cord injury is a challenging process and appropriate patient support and guidance are of utmost importance. Both physical and psychological aspects must be addressed. The complexity of spinal cord rehabilitation and a great need for individualised care suggest the need for specialised healthcare providers. Available studies emphasise the importance of managing secondary complications and an approach aiming to facilitate the individual’s reintegration into the community.57 58 Ideally, rehabilitation should begin as soon as acute management allows, but delayed rehabilitation also promotes significant improvements and neurological recovery.59

Neurological function recovers to some degree during the recovery period after a SCInf,13 60 and the potential for recovery seems to be greater for spontaneous compared with periprocedural SCInf.30 38 61 62 Based on the pooled analysis, the proportion of patients with severe spinal cord symptoms, ASIA scores A or B, was reduced by 18% at follow-up. The proportion of patients with mild deficits, ASIA scores C or D, increased by 38% at a mean follow-up of 35 months, and there were four patients with complete neurological recovery (ASIA score E).

The pooled data analysis showed that 71% of patients were able to walk with or without walking aids after an average follow-up of 35 months. Recovery of ambulation is reported at different frequencies in different studies and seems to reflect the relative contributions of spontaneous and periprocedural cases.5 34 63 Similarly, spontaneous SCInf were associated with a greater potential for ambulatory recovery as opposed to periprocedural ones.5 63

Mortality

During the calculated mean follow-up of two and a half years, mortality was estimated at 5%. This is considerably lower than previous estimates of 22%–23% in mixed cohorts of spontaneous and periprocedural cases.36 61 64 In support of the findings from our pooled analysis, Nedeltchev et al reported a mortality rate of 9% in a mixed cohort where only 16% were periprocedural cases.63 The mortality data thus supports the finding that spontaneous SCInf is associated with lower mortality and improved outcomes compared with periprocedural cases, and long-term strategies are of great importance.38

Limitations

The limitations of this review mainly derive from the inherent limitations of the articles included, including small sample sizes, intermediate to high risks of bias and observational designs on retrospective cohorts or case series. The heterogeneity of the data did not permit a quantitative meta-analysis and the generalisability of the results is hence limited. In addition, the studies included also reflect the current lack of definitive diagnostic criteria.

Conclusions and future perspectives

Spontaneous SCInf is a rare and often misdiagnosed condition. The multitude of diagnostic alternatives and the lack of definitive diagnostic guidelines and treatment protocols provide an impetus for continued research. Diagnostic criteria for SCInf, such as those proposed by Zalewski et al,18 should be integrated into the structured management of patients with acute myelopathy (figure 2). A systematic and uniform definition and management of SCInf would provide a foundation for continued clinical and scientific efforts. Currently, treatment is limited to secondary preventive measures. A better understanding of the pathological pathways preceding a spontaneous SCInf could perhaps allow the identification and treatment of individuals at risk. Continued research into the role of cardiovascular risk factors is essential.

Figure 2. Proposed flow chart for the management of patients with acute myelopathy. ScInf, spinal cord infarction.

Figure 2

Pharmacological treatment with platelet aggregation inhibitors in the aftermath of spontaneous SCInf is recommended, but the efficacy remains unclear. Only four instances of thrombolysis were identified. The difficulties in rapidly establishing a definitive diagnosis may partly explain why thrombolysis is so rarely used. However, the possibility of directly treating the inciting factor remains attractive and further studies are warranted. In cerebral stroke, neuroprotective agents have been advocated, but studies in SCInf are lacking.65 Similarly, immune modulation may play a role in future care.60

The relatively good potential for functional recovery, including ambulation, indicates the need for specialised multidisciplinary rehabilitation services with the capacity to manage patients in the long term.38

Supplementary material

online supplemental file 1
DOI: 10.1136/bmjno-2024-000754

Footnotes

Funding: AET is supported by Region Stockholm in a clinical research appointment.

Provenance and peer review: Not commissioned; internally peer reviewed.

Patient consent for publication: Not applicable.

Ethics approval: Not applicable.

Data availability statement

Data sharing not applicable as no datasets generated and/or analysed for this study.

References

  • 1.Faig J, Busse O, Salbeck R. Vertebral body infarction as a Confirmatory sign of spinal cord ischemic stroke report of three. Stroke . 1998;29:239–43. doi: 10.1161/01.STR.29.1.239. [DOI] [PubMed] [Google Scholar]
  • 2.Kim BR, Park KS, Kim HJ, et al. Features of non-traumatic spinal cord infarction on MRI: changes over time. PLoS One. 2022;17:e0274821. doi: 10.1371/journal.pone.0274821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Hsu JL, Cheng M-Y, Liao M-F, et al. The Etiologies and prognosis associated with spinal cord infarction. Ann Clin Transl Neurol. 2019;6:1456–64. doi: 10.1002/acn3.50840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Ros Castelló V, Sánchez Sánchez A, Natera Villalba E, et al. Spinal cord infarction: Aetiology, imaging findings, and Prognostic factors in a series of 41 patients. Neurologia (Engl Ed) 2021 doi: 10.1016/j.nrl.2020.11.014. [DOI] [PubMed] [Google Scholar]
  • 5.Ge L, Arul K, Stoner M, et al. Etiology and outcomes of spinal cord infarct: a case series from a level 1 trauma center. Global Spine J. 2020;10:735–40. doi: 10.1177/2192568219877863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Struhal W, Seifert-Held T, Lahrmann H, et al. Clinical core symptoms of posterior spinal artery ischemia. Eur Neurol. 2011;65:183–6. doi: 10.1159/000324722. [DOI] [PubMed] [Google Scholar]
  • 7.Rigney L, Cappelen-Smith C, Sebire D, et al. Nontraumatic spinal cord ischaemic syndrome. J Clin Neurosci. 2015;22:1544–9. doi: 10.1016/j.jocn.2015.03.037. [DOI] [PubMed] [Google Scholar]
  • 8.New PW, McFarlane CL. Survival following spinal cord infarction. Spinal Cord. 2013;51:453–6. doi: 10.1038/sc.2013.14. [DOI] [PubMed] [Google Scholar]
  • 9.Spencer SP, Brock TD, Matthews RR, et al. Three unique presentations of Atraumatic spinal cord infarction in the pediatric emergency Department. Pediatr Emerg Care. 2014;30:354–7. doi: 10.1097/PEC.0000000000000130. [DOI] [PubMed] [Google Scholar]
  • 10.New PW, McFarlane CL. Retrospective case series of outcomes following spinal cord infarction. Eur J Neurol. 2012;19:1207–12. doi: 10.1111/j.1468-1331.2012.03702.x. [DOI] [PubMed] [Google Scholar]
  • 11.Tubbs RS, Blouir MC, Romeo AK, et al. Spinal cord ischemia and Atherosclerosis: a review of the literature. Br J Neurosurg. 2011;25:666–70. doi: 10.3109/02688697.2011.578774. [DOI] [PubMed] [Google Scholar]
  • 12.Zalewski NL, Rabinstein AA, Krecke KN, et al. Characteristics of spontaneous spinal cord infarction and proposed diagnostic criteria. JAMA Neurol. 2019;76:56–63. doi: 10.1001/jamaneurol.2018.2734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Elksnis SM, Hogg JP, Cunningham ME. MR imaging of spontaneous spinal cord infarction. J Comput Assist Tomogr. 1991;15:228–32. doi: 10.1097/00004728-199103000-00007. [DOI] [PubMed] [Google Scholar]
  • 14.Pikija S, Kunz AB, Nardone R, et al. Spontaneous spinal cord infarction in Austria: a two-center comparative study. Ther Adv Neurol Disord. 2022;15 doi: 10.1177/17562864221076321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.English SW, Rabinstein AA, Flanagan EP, et al. Spinal cord transient ischemic attack. Neur Clin Pract. 2020;10:480–3. doi: 10.1212/CPJ.0000000000000778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Artemis D, Wolf M, Blahak C, et al. Diagnostic and Prognostic relevance of magnetic resonance imaging and electrophysiological findings in acute spinal ischemia. J Stroke Cerebrovasc Dis. 2017;26:459–64. doi: 10.1016/j.jstrokecerebrovasdis.2016.12.031. [DOI] [PubMed] [Google Scholar]
  • 17.Bar C, Cheuret E, Bessou P, et al. Childhood idiopathic spinal cord infarction: description of 7 cases and review of the literature. Brain Dev. 2017;39:818–27. doi: 10.1016/j.braindev.2017.05.009. [DOI] [PubMed] [Google Scholar]
  • 18.Zalewski NL, Rabinstein AA, Krecke KN, et al. Characteristics of spontaneous spinal cord infarction and proposed diagnostic criteria. JAMA Neurol. 2019;76:56. doi: 10.1001/jamaneurol.2018.2734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Fedaravičius A, Feinstein Y, Lazar I, et al. Successful management of spinal cord ischemia in a pediatric patient with Fibrocartilaginous embolism: illustrative case. J Neurosurg Case Lessons . 2021;2:CASE21380. doi: 10.3171/CASE21380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021:71. doi: 10.1136/bmj.n71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.El-Hajj VG, Stenimahitis V, Gharios M, et al. Spontaneous spinal cord Infarctions: a systematic review and pooled analysis protocol. BMJ Open. 2023;13:e071044. doi: 10.1136/bmjopen-2022-071044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Hsu C-Y, Cheng C-Y, Lee J-D, et al. Clinical features and outcomes of spinal cord infarction following vertebral artery dissection: a systematic review of the literature. Neurol Res. 2013;35:676–83. doi: 10.1179/1743132813Y.0000000183. [DOI] [PubMed] [Google Scholar]
  • 23.Ouzzani M, Hammady H, Fedorowicz Z, et al. Rayyan-a web and mobile App for systematic reviews. Syst Rev. 2016;5 doi: 10.1186/s13643-016-0384-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Yadav N, Pendharkar H, Kulkarni GB. Spinal cord infarction: clinical and radiological features. J Stroke Cerebrovasc Dis. 2018;27:2810–21. doi: 10.1016/j.jstrokecerebrovasdis.2018.06.008. [DOI] [PubMed] [Google Scholar]
  • 25.Ghandehari K, Gerami Sarabi MR, Maarufi P. Clinical evaluation of patients with spinal cord infarction in Mashhad, Iran. Stroke Res Treat. 2010;2010:942417. doi: 10.4061/2010/942417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Srikanth SG, Chandrashekhar HS, Shankar JJS, et al. Vertebral body signal changes in spinal cord infarction: histopathological confirmation. Neuroradiol J. 2007;20:580–5. doi: 10.1177/197140090702000518. [DOI] [PubMed] [Google Scholar]
  • 27.Yuh WTC, Marsh EE, Wang AK, et al. MR imaging of spinal cord and vertebral body infraction. American Journal of Neuroradiology. 1992;13:145–54. https://pubmed.ncbi.nlm.nih.gov/1595432/ Available. [PMC free article] [PubMed] [Google Scholar]
  • 28.Ashton C, Banham N, Needham M. Acute spontaneous spinal cord infarction: utilisation of hyperbaric oxygen treatment, cerebrospinal fluid drainage and Pentoxifylline. Diving Hyperb Med. 2020;50:325–31. doi: 10.28920/dhm50.4.325-331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Sechi E, Mariotto S, McKeon A, et al. Serum Neurofilament to magnetic resonance imaging lesion area ratio Differentiates spinal cord infarction from acute Myelitis. Stroke. 2021;52:645–54. doi: 10.1161/STROKEAHA.120.031482. [DOI] [PubMed] [Google Scholar]
  • 30.Monteiro L, Leite I, Pinto JA, et al. Spontaneous Thoracolumbar spinal cord infarction: report of six cases. Acta Neurol Scand. 1992;86:563–6. doi: 10.1111/j.1600-0404.1992.tb05487.x. [DOI] [PubMed] [Google Scholar]
  • 31.Cheng M-Y, Lyu R-K, Chang Y-J, et al. Spinal cord infarction in Chinese patients: clinical features, risk factors, imaging and prognosis. Cerebrovasc Dis . 2008;26:502–8. doi: 10.1159/000155988. [DOI] [PubMed] [Google Scholar]
  • 32.Pelser H, van Gijn J. Spinal infarction a follow-up study. Stroke. 1993;24:896–8. doi: 10.1161/01.str.24.6.896. [DOI] [PubMed] [Google Scholar]
  • 33.Alblas CL, Bouvy WH, Lycklama à Nijeholt GJ, et al. Acute spinal-cord ischemia: evolution of MRI findings. J Clin Neurol . 2012;8:218. doi: 10.3988/jcn.2012.8.3.218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Cheshire WP, Santos CC, Massey EW, et al. Spinal cord infarction: etiology and outcome. Neurology. 1996;47:321–30. doi: 10.1212/wnl.47.2.321. [DOI] [PubMed] [Google Scholar]
  • 35.Qureshi AI, Afzal MR, Suri MFK. A population-based study of the incidence of acute spinal cord infarction. J Vasc Interv Neurol. 2017;9:44–8. http://www.ncbi.nlm.nih.gov/pubmed/28702119%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC5501128 Available. [PMC free article] [PubMed] [Google Scholar]
  • 36.Robertson CE, Brown RD, Wijdicks EFM, et al. Recovery after spinal cord Infarcts: long-term outcome in 115 patients. Neurology. 2012;78:114–21. doi: 10.1212/WNL.0b013e31823efc93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Park D, Kim BH, Lee SE, et al. Spinal cord infarction: a single center experience and the usefulness of evoked potential as an early diagnostic tool. Front Neurol. 2020;11:563553. doi: 10.3389/fneur.2020.563553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Stenimahitis V, Fletcher-Sandersjöö A, El-Hajj VG, et al. Long-term outcomes following periprocedural and spontaneous spinal cord Infarctions: a population-based cohort study. Neurology. 2023;101:e114–24. doi: 10.1212/WNL.0000000000207377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Weidauer S, Nichtweiss M, Lanfermann H, et al. Spinal cord infarction: MR imaging and clinical features in 16 cases. Neuroradiology. 2002;44:851–7. doi: 10.1007/s00234-002-0828-5. [DOI] [PubMed] [Google Scholar]
  • 40.Kim SW, Kim RC, Choi BH, et al. Non-traumatic ischaemic Myelopathy: a review of 25 cases. Paraplegia. 1988;26:262–72. doi: 10.1038/sc.1988.40. [DOI] [PubMed] [Google Scholar]
  • 41.Nardone R, Bergmann J, Kronbichler M, et al. Magnetic resonance imaging and motor-evoked potentials in spinal cord infarction: report of two cases. Neurol Sci. 2010;31:505–9. doi: 10.1007/s10072-010-0263-z. [DOI] [PubMed] [Google Scholar]
  • 42.Allen CL, Bayraktutan U. Risk factors for ischaemic stroke. Int J Stroke. 2008;3:105–16. doi: 10.1111/j.1747-4949.2008.00187.x. [DOI] [PubMed] [Google Scholar]
  • 43.Teo KK, Rafiq T. Cardiovascular risk factors and prevention: a perspective from developing countries. Can J Cardiol. 2021;37:733–43. doi: 10.1016/j.cjca.2021.02.009. [DOI] [PubMed] [Google Scholar]
  • 44.Arboix A. Cardiovascular risk factors for acute stroke: risk profiles in the different subtypes of ischemic stroke. WJCC . 2015;3:418. doi: 10.12998/wjcc.v3.i5.418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Naess H, Romi F. Comparing patients with spinal cord infarction and cerebral infarction: clinical characteristics, and short-term outcome. Vasc Health Risk Manag. 2011;7:497–502. doi: 10.2147/VHRM.S22950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Wei J, Kang J, Hui B. Spinal cord infarction with a negative MRI finding: a case report and literature review. NM. 2022;13:53–60. doi: 10.4236/nm.2022.132005. [DOI] [Google Scholar]
  • 47.Masson C, Pruvo JP, Meder JF, et al. Spinal cord infarction: clinical and magnetic resonance imaging findings and short term outcome. J Neurol Neurosurg Psychiatry . 2004;75:1431–5. doi: 10.1136/jnnp.2003.031724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Pikija S, Mutzenbach JS, Kunz AB, et al. Delayed hospital presentation and neuroimaging in non-surgical spinal cord infarction. Front Neurol. 2017;8:143. doi: 10.3389/fneur.2017.00143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.van Everdingen KJ, van der Grond J, Kappelle LJ, et al. Diffusion-weighted magnetic resonance imaging in acute stroke. Stroke. 1998;29:1783–90. doi: 10.1161/01.str.29.9.1783. [DOI] [PubMed] [Google Scholar]
  • 50.Thurnher MM, Bammer R. Diffusion-weighted MR imaging (DWI) in spinal cord ischemia. Neuroradiology. 2006;48:795–801. doi: 10.1007/s00234-006-0130-z. [DOI] [PubMed] [Google Scholar]
  • 51.Nogueira RG, Ferreira R, Grant PE, et al. Restricted diffusion in spinal cord infarction demonstrated by magnetic resonance line scan diffusion imaging. Stroke. 2012;43:532–5. doi: 10.1161/STROKEAHA.111.624023. [DOI] [PubMed] [Google Scholar]
  • 52.Lin WP, Kuan TS, Lin CI, et al. Spinal cord infarction during physical exertion due to Polycythemia Vera and Aortoiliac occlusive disease: a case report. Medicine (Baltimore) 2018;97:e12181. doi: 10.1097/MD.0000000000012181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Robertson CS, Foltz R, Grossman RG, et al. Protection against experimental ischemic spinal cord injury. J Neurosurg. 1986;64:633–42. doi: 10.3171/jns.1986.64.4.0633. [DOI] [PubMed] [Google Scholar]
  • 54.Lee DW, Choi YH. Spinal cord infarction mimicking ischemic heart disease. Clin Exp Emerg Med. 2017;4:109–12. doi: 10.15441/ceem.16.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Focke JK, Seitz RJ. Reversal of acute spinal cord ischemia by intravenous Thrombolysis. Neurol Clin Pract. 2021;11:e975–6. doi: 10.1212/CPJ.0000000000001097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Lynch K, Oster J, Apetauerova D, et al. Spinal cord stroke: acute imaging and intervention. Case Rep Neurol Med. 2012 doi: 10.1155/2012/706780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Kwon BK, Banaszek D, Kirshblum S. Advances in the rehabilitation of the spinal cord-injured patient: the Orthopaedic Surgeons’ perspective. J Am Acad Orthop Surg. 2019;27:e945–53. doi: 10.5435/JAAOS-D-18-00559. [DOI] [PubMed] [Google Scholar]
  • 58.Shah N, Shrestha B, Subba K. Spinal cord injury rehabilitation in Nepal. JNMA J Nepal Med Assoc . 2013;52:427–31. doi: 10.31729/JNMA.1531. [DOI] [PubMed] [Google Scholar]
  • 59.Scivoletto G, Morganti B, Cosentino E, et al. Utility of delayed spinal cord injury rehabilitation: an Italian study. Neurol Sci. 2006;27:86–90. doi: 10.1007/s10072-006-0605-z. [DOI] [PubMed] [Google Scholar]
  • 60.Malone K, Amu S, Moore AC, et al. Immunomodulatory therapeutic strategies in stroke. Front Pharmacol. 2019;10:630. doi: 10.3389/fphar.2019.00630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Salvador de la Barrera S, Barca-Buyo A, Montoto-Marqués A, et al. Spinal cord infarction: prognosis and recovery in a series of 36 patients. Spinal Cord. 2001;39:520–5. doi: 10.1038/sj.sc.3101201. [DOI] [PubMed] [Google Scholar]
  • 62.Foo D, Rossier AB. Anterior spinal artery syndrome and its natural history. Paraplegia. 1983;21:1–10. doi: 10.1038/sc.1983.1. [DOI] [PubMed] [Google Scholar]
  • 63.Nedeltchev K, Loher TJ, Stepper F, et al. Long-term outcome of acute spinal cord ischemia syndrome. Stroke. 2004;35:560–5. doi: 10.1161/01.STR.0000111598.78198.EC. [DOI] [PubMed] [Google Scholar]
  • 64.Hanson SR, Romi F, Rekand T, et al. Long-term outcome after spinal cord Infarctions. Acta Neurol Scand. 2015;131:253–7. doi: 10.1111/ane.12343. [DOI] [PubMed] [Google Scholar]
  • 65.Mehta A, Mahale R, Buddaraju K, et al. Efficacy of Neuroprotective drugs in acute ischemic stroke: is it helpful. J Neurosci Rural Pract. 2019;10:576–81. doi: 10.1055/s-0039-1700790. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.WT Y, 3rd MEE, AK W. MR imaging of spinal cord and vertebral body infarction. AJNR Am J Neuroradiol. 1992;13:145–54. https://pubmed.ncbi.nlm.nih.gov/1595432/ Available. [PMC free article] [PubMed] [Google Scholar]
  • 67.Pelser H, van Gijn J. Spinal infarction. A follow-up study. Stroke. 1993;24:896–8. doi: 10.1161/01.STR.24.6.896. [DOI] [PubMed] [Google Scholar]
  • 68.Zalewski NL, Rabinstein AA, Wijdicks EFM, et al. Spontaneous posterior spinal artery infarction. Neurology. 2018;91:414–7. doi: 10.1212/WNL.0000000000006084. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

online supplemental file 1
DOI: 10.1136/bmjno-2024-000754

Data Availability Statement

Data sharing not applicable as no datasets generated and/or analysed for this study.


Articles from BMJ Neurology Open are provided here courtesy of BMJ Publishing Group

RESOURCES